LRRK2 and Parkinson disease: The combination therapy may also be applicable to inherited PD cases with LRRK2, PINK1 and α-syn gene mutations, as PD gene mutations can disturb the TH-DA pathway and up-regulate DA production, leading to DA-dependent neurodegeneration.